Licence Agreement with Kobayashi for the Commercial Launch of Fortacin™ in JapanLicence Agreement • July 25th, 2024
Contract Type FiledJuly 25th, 2024This announcement is made by the Company in compliance with the disclosure requirements under Rule 13.09 of the Listing Rules and the Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).